A detailed history of Walleye Capital LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Walleye Capital LLC holds 40,806 shares of ACAD stock, worth $696,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,806
Previous 30,900 32.06%
Holding current value
$696,558
Previous $502,000 25.1%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.14 - $19.14 $954,183 - $1.21 Million
-63,024 Reduced 60.7%
40,806 $628,000
Q2 2024

Aug 14, 2024

BUY
$14.62 - $18.42 $944,890 - $1.19 Million
64,630 Added 164.87%
103,830 $1.69 Million
Q1 2024

May 15, 2024

SELL
$17.79 - $30.86 $3.62 Million - $6.28 Million
-203,505 Reduced 83.85%
39,200 $724,000
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $2.99 Million - $4.58 Million
144,104 Added 146.15%
242,705 $7.6 Million
Q3 2023

Nov 14, 2023

BUY
$20.84 - $33.47 $1.56 Million - $2.51 Million
74,850 Added 315.14%
98,601 $2.05 Million
Q2 2023

Aug 14, 2023

SELL
$17.8 - $25.65 $7.03 Million - $10.1 Million
-395,092 Reduced 94.33%
23,751 $568,000
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $4.75 Million - $6.09 Million
290,923 Added 227.43%
418,843 $7.88 Million
Q4 2022

Feb 14, 2023

SELL
$14.2 - $18.63 $1.16 Million - $1.52 Million
-81,609 Reduced 38.95%
127,920 $2.04 Million
Q3 2022

Nov 14, 2022

SELL
$14.11 - $18.27 $366,831 - $474,983
-25,998 Reduced 11.04%
209,529 $3.43 Million
Q2 2022

Aug 08, 2022

BUY
$13.01 - $27.22 $2.76 Million - $5.78 Million
212,185 Added 909.03%
235,527 $3.32 Million
Q1 2022

May 16, 2022

SELL
$20.94 - $27.5 $867,607 - $1.14 Million
-41,433 Reduced 63.96%
23,342 $565,000
Q4 2021

Mar 03, 2022

SELL
$16.79 - $27.09 $898,281 - $1.45 Million
-53,501 Reduced 45.23%
64,775 $0
Q3 2021

Nov 15, 2021

BUY
$15.78 - $24.77 $1.57 Million - $2.46 Million
99,276 Added 522.51%
118,276 $1.97 Million
Q2 2021

Aug 16, 2021

BUY
$19.4 - $27.42 $368,600 - $520,980
19,000 New
19,000 $463,000
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $26,269 - $38,902
-830 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$36.21 - $51.4 $255,027 - $362,010
-7,043 Reduced 89.46%
830 $36,000
Q3 2019

Nov 14, 2019

BUY
$22.22 - $44.01 $174,938 - $346,490
7,873 New
7,873 $283,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.